CALL FOR PROPOSALS
2022 HSCI DIABETES PROGRAM PILOT GRANTS
'Learning from cancer immunology to cure autoimmune diabetes'
AWARD AMOUNT
Up to $100,000 per year per lab for up to two years
POSTED DATE
December 6, 2021
DEADLINE FOR APPLICATION
January 28, 2022
ANTICIPATED AWARD DATE
April 1, 2022
The Harvard Stem Cell Institute (HSCI) Diabetes Program invites applications for pilot grant funding. The purpose of this call for applications is to fund innovative projects rooted in our understanding of tumor-immune interactions to avert the immune attack on pancreatic islet cells that underlies type 1 diabetes. A particular focus of the Diabetes Program lies in developing solutions that will enable the transplantation of stem cell-derived islet cells into patients with autoimmune diabetes. Approaches of interest include – but are not limited to – novel immune interventions to regulate or eliminate autoreactive T lymphocytes, interventions to modify local antigen presentation, and genetic manipulations of stem cell-derived islet cells to protect them against allo- and autoimmunity. Collaborative proposals are welcome, particulary where one of the labs has expertise in diabetes research. The HSCI diabetes Program intends to award up to two grants as a result of this call for proposals.... Read more about Call for Proposals: 2022 HSCI Diabetes Program Pilot Grants - 'Learning from cancer immunology to cure autoimmune diabetes'
